Axcella Health Inc.
DelistedCIK 1633070fmd_0S8VXSVDY98DH6STVADX980EVEManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2017 to Jun 30, 2023, 23 periods
Latest annual · FY2022
Millions- Operating income
- (77)
- Net income
- (81)
- Free cash flow
- (70)
Latest quarter · Q2 FY2023
Millions- Operating income
- (4)
- Net income
- (3)
- Free cash flow
- (9)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2017 to FY2022
- n/m
Axcella Health Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Operating income | -$77 million | -$61.8 million | 10-K 2023-03-30 · proof | |
| Net income | -$81.2 million | -$64.6 million | 10-K 2023-03-30 · proof | |
| Cash from operating activities | -$69.6 million | -$54.2 million | 10-K 2023-03-30 · proof | |
| Free cash flow | -$70 million | -$54.5 million | 10-K 2023-03-30 · proof | |
| Total assets | $18.9 million | $57.7 million | -67.2% | 10-K 2023-03-30 · proof |
| Total liabilities | $14.8 million | $35.7 million | -58.7% | 10-K 2023-03-30 · proof |
| Cash and cash equivalents | $17.1 million | $23.6 million | -27.3% | 10-K 2023-03-30 · proof |
- What was Axcella Health Inc.'s operating income in fiscal 2022?
- Axcella Health Inc. reported operating income of -$77 million for fiscal 2022 (the year ended Dec 31, 2022), against -$61.8 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What was Axcella Health Inc.'s net income in fiscal 2022?
- Axcella Health Inc. reported net income of -$81.2 million for fiscal 2022 (the year ended Dec 31, 2022), against -$64.6 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What was Axcella Health Inc.'s cash from operating activities in fiscal 2022?
- Axcella Health Inc. reported cash from operating activities of -$69.6 million for fiscal 2022 (the year ended Dec 31, 2022), against -$54.2 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What was Axcella Health Inc.'s free cash flow in fiscal 2022?
- Axcella Health Inc. reported free cash flow of -$70 million for fiscal 2022 (the year ended Dec 31, 2022), against -$54.5 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What are Axcella Health Inc.'s total assets?
- As of Dec 31, 2022, Axcella Health Inc. reported total assets of $18.9 million, against $57.7 million a year earlier (-67.2%). Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What are Axcella Health Inc.'s total liabilities?
- As of Dec 31, 2022, Axcella Health Inc. reported total liabilities of $14.8 million, against $35.7 million a year earlier (-58.7%). Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What are Axcella Health Inc.'s cash and cash equivalents?
- As of Dec 31, 2022, Axcella Health Inc. reported cash and cash equivalents of $17.1 million, against $23.6 million a year earlier (-27.3%). Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1633070&period_type=annual&limit=5"Information only, not investment advice.